Price of Mounjaro could be discounted in UK pharmacies
Popular weight loss The company behind the drug Mounjaro offered UK suppliers a discounted agreement that is expected to limit the price increase to consumers since September.
At the beginning of this month, Eli Lilly explained that the drug puts up to 170% of the list price, which may mean that the highest dose increases from £ 122 to £ 330 per month.
However, the BBC understands that the highest dose will be sold to suppliers for £ 247.50.
Pharmacies and other special weight loss services will add their own signs to consumers, but this means that the price increase of patients is not as big as they are initially scared.
Eli Lilly said that the Mounjaro price of England should be increased to be more compatible with higher prices in Europe and the United States.
US President Donald Trump had previously complained about the high drug cost in the USAHe threatened the pharmaceutical industry compared to other countries and did not move.
The agreement does not affect the price paid by NHS, as the service negotiates its own affected ratio to the recipe.
Weekly injection works by allowing you to eat less and can help people lose 20% of their body weight.
It is currently thought to be about 1.5 million people in Mounjaro, which are currently more than half in Mounjaro in the UK. Estimates, online services and High Street pharmacies by purchasing, proposing nine payment for 10 people for these drugs.
Eli Lilly said: “We are working with special providers on commercial arrangements to maintain purchases and wait for them to pass to patients when the change comes into force on September 1.
He continued: “We see that the providers respond to the list price change in different ways with a number of options for appropriate patients.”
The price paid by the consumer depends on which service of the weight loss drug purchased.
Some offer more lifestyle and diet support than others.
BBC spoke with a number of services and the price increase for customers can be less than 50% for higher doses and can be kept less for lower doses.
Olivier Picard of the National Pharmacy Association said: “Pharmacists will do their best to support patients when prices change.
“This discount will reduce some of the increase, but patients should still expect an increase in prices from 1 September.
“Pharmacies are working hard to support their patients and to investigate whether there are options for minimizing deterioration in treatment programs.”
